J. Goldman & Co LP - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 138 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2021$2,278,000
+25.6%
96,347
+25.9%
0.09%
+51.7%
Q1 2021$1,814,000
-37.9%
76,557
-47.5%
0.06%
-60.8%
Q4 2020$2,920,000
+102.2%
145,765
+110.1%
0.15%
+51.0%
Q3 2020$1,444,000
-62.1%
69,364
-68.2%
0.10%
-58.5%
Q2 2020$3,814,000
-37.6%
217,954
-41.8%
0.24%
-68.0%
Q1 2020$6,116,000
+158.6%
374,542
+226.0%
0.74%
+333.5%
Q4 2019$2,365,000
+52.4%
114,902
-15.0%
0.17%
+46.6%
Q3 2019$1,552,000
+237.4%
135,199
+286.3%
0.12%
+262.5%
Q2 2019$460,000
-87.1%
34,999
-85.1%
0.03%
-84.0%
Q1 2019$3,558,000
-80.6%
235,015
-78.0%
0.20%
-85.8%
Q4 2018$18,318,000
-23.8%
1,066,847
-34.6%
1.41%
-16.1%
Q3 2018$24,054,000
+259.6%
1,631,885
+481.8%
1.68%
+387.5%
Q2 2018$6,690,000
+16.9%
280,510
+25.2%
0.34%
+41.4%
Q1 2018$5,724,000
+4.4%
224,024
-57.1%
0.24%
-11.9%
Q3 2017$5,482,000
+40.9%
522,593
+68.0%
0.28%
+31.3%
Q2 2017$3,891,000
+12.4%
311,000
-9.6%
0.21%
+23.4%
Q1 2017$3,462,000
-1.1%
344,129
+53.0%
0.17%
-26.3%
Q4 2016$3,501,000
+133.1%
224,850
+188.3%
0.23%
+172.9%
Q3 2016$1,502,000
+28.0%
78,000
-21.2%
0.08%
+39.3%
Q2 2016$1,173,00099,0000.06%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q4 2020
NameSharesValueWeighting ↓
Tejara Capital Ltd 289,803$6,477,0973.67%
Tamarack Advisers, LP 185,000$4,134,7502.68%
Rubric Capital Management LP 3,175,000$70,961,2502.66%
Eventide Asset Management 2,631,334$58,810,3151.06%
Camber Capital Management LP 1,050,000$23,4680.77%
EMERALD MUTUAL FUND ADVISERS TRUST 559,480$12,504,3780.76%
EMERALD ADVISERS, LLC 690,487$15,432,3800.75%
Values First Advisors, Inc. 43,507$972,3740.63%
AlphaCentric Advisors LLC 49,500$1,106,3250.63%
SummerHaven Investment Management, LLC 33,666$752,4350.55%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders